EUCTR2009-010145-31-DE进行中(未招募)不适用
A phase IV, open-label, multi-center follow-up study to determine the persistence of tick-borne encephalitis (TBE)-specific antibody responses among children and adolescents previously immunized against TBE. - M48P3E1
ovartis Vaccines and Diagnostics GmbH & Co. KG0 个研究点开始时间: 2009年2月17日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Healthy M48P3 study subjects with parental or legal guardian informed consent (health status as determined by review of medical history and physical examination and in the clinical judgment of the investigator)
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects who did not receive complete schedule of primary vaccination in M48P3.
- •Subjects enrolled in other investigational studies at the same time and within the last three months
- •Subjects with any condition which, in the opinion of the investigator, might interfere with the evaluation of the study objectives
研究者
相似试验
招募中
4 期
A clinical study to assess the long-term immune response after primary vaccination and immune response after re-vaccination with typhoid conjugate vaccineCTRI/2019/07/019996Cadila Healthcare Ltd
进行中(未招募)
1 期
Study of management of pasireotide-induced hyperglycemia in adult patients with Cushing’s disease or acromegalyEUCTR2012-002916-16-BEovartis Pharma Services AG132
进行中(未招募)
1 期
Study of management of pasireotide-induced hyperglycemia in adult patients with Cushing’s disease or acromegalyCushing's disease and acromegalyMedDRA version: 19.0Level: LLTClassification code 10011651Term: Cushing's diseaseSystem Organ Class: 100000004860MedDRA version: 19.0Level: LLTClassification code 10000600Term: Acromegaly and gigantismSystem Organ Class: 100000004860EUCTR2012-002916-16-PLovartis Pharma Services AG133
进行中(未招募)
1 期
Study of management of pasireotide-induced hyperglycemia in adult patients with Cushing’s disease or acromegalyEUCTR2012-002916-16-DEovartis Pharma Services AG249
招募中
4 期
To optimize management of drug induced increase in blood sugar with incretin based therapy or insulin in adult patients with Cushingâ??s disease (characterized by obesity of the trunk & face, high blood pressure, fatigue) or acromegaly (marked by enlargement of bones of extremities, face & jaw)CTRI/2015/02/005498ovartis Healthcare Pvt Ltd133
